Added to YB: 2025-12-10
Pitch date: 2025-12-06
ABT [bullish]
Abbott Laboratories
-22.58%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide.
Market Cap
$163.9B
Pitch Price
$123.22
Price Target
N/A
Dividend
2.68%
EV/EBITDA
15.77
P/E
26.36
EV/Sales
4.24
Sector
Health Care Equipment and Supplies
Category
value
Show full summary:
Institutional Order Flow Analysis: Decoding the 'Smart Money' Bet on Abbott Laboratories (ABT)
ABT: Institutional whale sold 1,000 Dec '26 $110 puts @ $5.10, targeting $104.90 entry (13x P/E). NEC litigation risk fading after late 2025 court wins. Lingo/Libre Rio driving 16.2% Diabetes Care growth. 8% annualized return vs 3.6% Treasuries. Dividend King at fire-sale valuation if assigned.
Read full article (4 min)